Page last updated: 2024-08-23

ursodeoxycholic acid and Cytokine Release Syndrome

ursodeoxycholic acid has been researched along with Cytokine Release Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Abdulrab, S; Al-Maweri, S; Halboub, E1

Other Studies

1 other study(ies) available for ursodeoxycholic acid and Cytokine Release Syndrome

ArticleYear
Ursodeoxycholic acid as a candidate therapeutic to alleviate and/or prevent COVID-19-associated cytokine storm.
    Medical hypotheses, 2020, Volume: 143

    Topics: Anti-Inflammatory Agents; Apoptosis; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Humans; Models, Theoretical; Pandemics; Pneumonia, Viral; SARS-CoV-2; Ursodeoxycholic Acid

2020